07:00 , Jul 20, 2009 |  BC Week In Review  |  Company News

Amedrix dermatology, musculoskeletal news

Thomas Graeve founded newco Amedrix to develop cell-free products based on animal collagen for wound regeneration and reconstruction of degenerated soft tissue. Graeve will serve as CEO of the newco, which initially will focus on...
08:00 , Feb 5, 2007 |  BioCentury  |  Finance

AIM iceberg

AIM iceberg Company Date Raised Post-$ Mcap 12/29/06 Chg York Pharma (LSE:YRK) 4/16/04 £1.0 £2.3 £23.2 932% Lipoxen (LSE:LPX) 1/17/06 £3.8 £13.1 £35.4 169% Vectura (LSE:VEC) 6/25/04 £20.0 £60.0 £156.8 161% ReNeuron (LSE:RENE) 8/5/05 £9.5...
07:00 , Oct 2, 2006 |  BioCentury  |  Finance

IPO performance

IPO performance North America Company Date Raised Post-$ 9/29 Mcap Chg Omrix (OMRI) 4/20/06 $39.5 $148.3 $279.3 88% Acorda (ACOR) 2/10/06 $36.5 $117.7 $179.5 53% Novacea (NOVC) 5/9/06 $44.9 $149.4 $173.5 16% Altus (ALTU) 1/26/06...
07:00 , Jul 3, 2006 |  BioCentury  |  Finance

IPO performance

IPO performance Company Date Raised Post-$ 6/30 Mcap % chg Replidyne (RDYN) 6/28/06 $45.0 $264.3 $274.3 4% OncoMethylome (Euronext:ONCO) 6/26/06 $27.5 $93.9 $95.2 1% BioXell (SWX:BXLN) 6/21/06 $46.9 $187.8 $188.0 0% Curalogic (CSE:CURN) 5/31/06 $36.9...
07:00 , Apr 3, 2006 |  BioCentury  |  Finance

IPO performance

IPO performance Company Date Raised Post-IPO 3/31 mcap % chg Syntopix (LSE:SYN) 3/23/06 $7.0 $17.7 $18.8 6% Aqua Bounty (LSE:ABTX) 3/15/06 $34.6 $128.4 $127.9 0% Alexza (ALXA) 3/8/06 $44.0 $180.8 $220.4 22% AGI Therap (ISE:AGI;...
08:00 , Mar 6, 2006 |  BioCentury  |  Finance

Hustle and bustle at AIM

There is a growing belief among companies that London's Alternative Investment Market has shed the credibility concerns that once plagued it and is now an acceptable stock market for the blue chip international institutions that...